| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G | Report | SCHEDULE 13G | May 17, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | AMENDMENT TO SC 13G | Feb 14, 2022 | |
| SC 13G/A | Report | OCUPHIRE PHARMA, INC. | Jan 18, 2022 | |
| SC 13G | Report | SC 13G | Mar 26, 2021 | |
| SC 13G | Report | SC 13G | Mar 17, 2021 | |
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 16, 2021 | |
| SC 13G/A | Report | OCUPHIRE PHARMA, INC. | Feb 2, 2021 | |
| SC 13G | Report | THE SCHEDULE 13G | Nov 16, 2020 | |
| SC 13G | Report | ACQUISITION OF BENEFICIAL OWNERSHIP | Nov 16, 2020 | |
| SC 13G | Report | EMPERY ASSET MANAGEMENT, LP | Nov 12, 2020 | |
| SC 13G | Report | Aug 10, 2020 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2019 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2019 | |
| SC 13G | Report | Feb 5, 2019 | ||
| SC 13G | Report | SC 13G | Oct 29, 2018 | |
| SC 13G | Report | SC 13G | Oct 26, 2018 | |
| SC 13G/A | Report | REXAHN PHARMACEUTICALS, INC. | Jan 17, 2017 | |
| SC 13G/A | Report | SABBY 13G-A RNN 1.10.17 | Jan 10, 2017 | |
| SC 13G | Report | SABBY 13G RNN 2.29.16 | Feb 29, 2016 | |
| SC 13G/A | Report | REXAHN PHARMACEUTICALS, INC. | Jan 19, 2016 | |
| SC 13G | Report | REXAHN PHARMACEUTICALS, INC. | Nov 10, 2015 | |
| SC 13G/A | Report | SABBY 13G-A RNN 01.07.14 | Jan 7, 2014 | |
| SC 13G/A | Report | SABBY 13G-A RNN 01.28.13 | Jan 28, 2013 | |
| SC 13G | Report | SABBY 13G RNN 12.4.12 | Dec 4, 2012 | |
| SC 13G | Report | SC 13G | Jan 28, 2011 |